Skip to main content
Clinical Trials/ACTRN12611000923965
ACTRN12611000923965
Recruiting
Phase 3

The effectiveness of functional electrical stimulation cycling on urine output, lower limb swelling and spasticity in recent spinal cord injury: a randomised control trial.

Associate Professor Lisa Harvey0 sites14 target enrollmentAugust 29, 2011

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Associate Professor Lisa Harvey
Enrollment
14
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 29, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Associate Professor Lisa Harvey

Eligibility Criteria

Inclusion Criteria

  • Participants will be included if;
  • \- they have sustained a SCI lesion (traumatic or non traumatic) within the preceding 6 months
  • \- they are currently receiving inpatient rehabilitation and will remain an inpatient for at least 8 weeks after initial screening as part of their standard rehabilitation and medical treatment.
  • \- their legs muscles are responsive to Electrical Stimulation and can tolerate \>20mins of FES cycling over an hour period.
  • \- they have a diagnosed AIS A, B or C lesion with less than 5/50 lower limb strength according to the International Standards for Neurological Classification of SCI.
  • \- they are 16 years of age or over and are able to provide informed consent.
  • \- they are deemed medically fit to participate in the study as per their treating Consultant.
  • \- they are able to speak sufficient English to allow them to participate in the study without the assistance of a translator.

Exclusion Criteria

  • Participants will be excluded if they;
  • \- have significant lower limb injury, pathology or contracture limiting use of FES cycling (e.g., decreased range of motion, recent or unhealed fracture, open wound or severe osteoporosis)
  • \- have a pacemaker / stimulator or are pregnant.
  • are non\-compliant with their inpatient rehabilitation program.
  • \- have diabetes, hyponatremia or severe renal / hepatic dysfunction.
  • \- have uncontrolled autonomic dysreflexia
  • \- have a cognitive impairment or other medical condition including psychiatric, behavioural or terminal illness limiting adherence to the Protocol or participation in the study .

Outcomes

Primary Outcomes

Not specified

Similar Trials